
Metric-Based Presentations
These online survey-based studies are ideal for learning what other companies are doing, how they measure what they do, what resources they devote to activities, what they find effective, and other insights. These are useful for doing a gap analysis.
 | Brand Management and Product Leadership |
| |
 | Business Communications |
| |
 | Business Operations |
| |
 | Clinical Operations |
| |
 | Competitive and Business Intelligence |
| |
 | Customer Service |
| |
 | GBC Conferences |
| |
 | Human Resources |
| |
 | Industry |
| |
 | Internet |
| |
 | Knowledge Management |
| |
 | Market Access |
| |
 | Market Research, Analytics and Forecasting |
| |
 | Marketing Management |
| |
 | Medical Affairs |
| |
 | Memberships |
| |
 | New Product Development |
| |
| |  |
| |  |
| |  |
| Profiles of In-Licensing Organizations 2   
|
This 16-page document profiles in-licensing organizations at five leading pharmaceutical companies... (ID 4496) Companies Profiled: AstraZeneca, Sanofi-aventis, Roche, Johnson & Johnson, more ... Price: $505.95
| |
|  |
| Profiles of In-Licensing Organizations 1   
|
This 13-page document profiles in-licensing organizations at four leading pharmaceutical companies... (ID 4495) Companies Profiled: AstraZeneca, Sanofi-aventis, Roche, Johnson & Johnson, more ... Price: $482.95
| |
|  |
| |  |
| In-Licensing Organization Structure  
|
This 19-page document examines key elements that determine the structure of high-performing in-licensing operations... (ID 4498) Companies Profiled: AstraZeneca, Sanofi-aventis, Bristol-Myers Squibb, GlaxoSmithKline, more ... Price: $574.95
| |
|  |
| |  |
| Top Factors for Effective In-Licensing Organizations  
|
This 11-page document provides a comprehensive overview of of insights and recommendations for building and managing an effective product in-licensing organization based on in-depth interviews with business development leaders from top pharmaceutical companies... (ID 4494) Companies Profiled: AstraZeneca, Sanofi-aventis, Roche, Johnson & Johnson, more ... Price: $410.00
| |
|  |
| Portfolio Development, Management & Measurement  
|
Leading companies invest considerable staff, time, resources and share of mind in the area of portfolio development, management and measurement... (ID 4317) Companies Profiled: Allergan, Abbott, Bayer, Bristol-Myers Squibb, more ... Price: $1249.95
| |
|  |
| Managing Processes, Tools and Techniques 
|
When it comes to managing the tools and processes of early-stage marketers, benchmark partners stress the importance of executing fundamentals: managing processes, managing across functions, working effectively among teams and departments, and conducting effective market research that will yield insights and pathways to commercial success... (ID 4316) Companies Profiled: Allergan, Abbott, Bayer, Bristol-Myers Squibb, more ... Price: $1449.95
| |
|  |
| |  |
| Optimizing Process Integration Through Structure and Resources  
|
Portfolio management and, especially, commercialization functions are becoming more critical to company bottom-line performance as a result of numerous internal and external factors, including weak drug pipelines and intensive pharmaceutical competition... (ID 4314) Companies Profiled: Allergan, Abbott, Bayer, Bristol-Myers Squibb, more ... Price: $1099.95
| |
|  |
| Early Stage Product Commercialization: Summary and Lessons Learned 
|
Since the percentage of successful compounds is so small and the development cycle so long, leading pharmaceutical companies strive to allocate resources to compounds with the greatest potential market value, and they begin investing marketing dollars in those drugs early in the development process... (ID 4312) Companies Profiled: Allergan, Abbott, Bayer, Bristol-Myers Squibb, more ... Price: $824.95
| |
|  |
| |  |
| |  |
| |  |
 | Patient Focused Services |
| |
 | Product Launch |
| |
 | Quality, Compliance and Regulatory |
| |
 | R and AS Conferences |
| |
 | Sales and Marketing |
| |
 | Sales Leadership |
| |
 | Samples and Free Reports |
| |
 | (Not Categorized) |
| |
|